As of 2025-04-28, the Intrinsic Value of Pharmadrug Inc (PHRX.CN) is -0.63 CAD. This PHRX.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.01 CAD, the upside of Pharmadrug Inc is -6,426.80%.
Based on its market price of 0.01 CAD and our intrinsic valuation, Pharmadrug Inc (PHRX.CN) is overvalued by 6,426.80%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.63 - -0.63 | -0.63 | -6,426.80% |
| P/E | 0.01 - 0.01 | 0.01 | 26.5% |
| DDM - Stable | (0.80) - (1.75) | (1.28) | -12853.5% |
| DDM - Multi | (0.71) - (1.22) | (0.90) | -9106.7% |
| Market Cap (mil) | 1.05 |
| Beta | 1.95 |
| Outstanding shares (mil) | 104.56 |
| Enterprise Value (mil) | 2.32 |
| Market risk premium | 5.10% |
| Cost of Equity | 12.81% |
| Cost of Debt | 5.00% |
| WACC | 7.70% |